Clinical Trial: Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07166783) titled 'Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol' on Aug. 22.

Brief Summary: Pharmacokinetics, pharmacological effects and safety of single dose of 7.5mg Tolvaptan tablet in healthy male subjects

Study Start Date: June 16, 2011

Study Type: INTERVENTIONAL

Condition: Health Subjects

Intervention: DRUG: Tolvaptan

single dose oral administration of 7.5mg Tolvaptan

Recruitment Status: COMPLETED

Sponsor: Otsuka Beijing Research Institute

Published by HT Digital Content Services with permission from Health Daily Digest....